Lansoprazole
Product Images NDC 55648-670

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 55648-670). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wockhardt Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container Label (15 mg 1000c)

Container Label (15 mg 1000c)
Each capsule of this medication (NDC 64679-669-05) contains 15 mg of lansoprazole in an enteric-coated granule form. The capsule is imprinted with product identification code "669 Delayed Release". It should not be accepted if the bottle seal is broken or missing. The medication should be dispensed in a tightly sealed container that meets USP standards. The full prescribing information is available in the package insert. This medication should be kept out of the reach of children and stored at 20°-25°C (68°-77°F) in a USP controlled room temperature.*
FDA Label Image

Container Label (30 mg 1000c)

Container Label (30 mg 1000c)
This is a description of a drug contained in pink and black capsules, each capsule contains 30 mg of lansoprazole. The capsules are imprinted with a product identification code and they are classified as Delayed-Release S5. The container comes with instructions not to accept the drug if the seal is broken or missing. The drug should be kept in a USP tight container and instructions for use are enclosed. The drug is only available with a prescription, and should be kept out of the reach of children. The drug should be stored at a temperature range of 20°-25°C (68°-77°F).*
FDA Label Image

Structure (Lansodrcapsrx M Figure 01)

FDA Label Image

Figure 1 (Lansodrcapsrx M Figure 02)

Figure 1 (Lansodrcapsrx M Figure 02)
This appears to be a table showing the mean severity of day heartburn for evaluable patients, with different treatments (Lansoprazole, Esomeprazole) listed, and the study day along the x-axis. However, the table is incomplete and it is not clear what the y-axis values represent.*
FDA Label Image

Figure 2 (Lansodrcapsrx M Figure 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.